Cullen Louise, Aldous Sally, Than Martin, Greenslade Jaimi H, Tate Jillian R, George Peter M, Hammett Christopher J, Richards A Mark, Ungerer Jacobus P J, Troughton Richard W, Brown Anthony F T, Flaws Dylan F, Lamanna Arvin, Pemberton Christopher J, Florkowski Christopher, Pretorius Carel J, Chu Kevin, Parsonage William A
Royal Brisbane and Women's Hospital, Herston, QLD, Australia; Queensland University of Technology, Brisbane, QLD, Australia.
Christchurch Hospital, Christchurch, New Zealand.
Clin Biochem. 2014 Apr;47(6):321-6. doi: 10.1016/j.clinbiochem.2013.11.019. Epub 2013 Dec 5.
Concentrations of troponin measured with high sensitivity troponin assays are raised in a number of emergency department (ED) patients; however many are not diagnosed with acute myocardial infarction (AMI). Clinical comparisons between the early use (2h after presentation) of high sensitivity cardiac troponin T (hs-cTnT) and I (hs-cTnI) assays for the diagnosis of AMI have not been reported.
Early (0 h and 2 h) hs-cTnT and hs-cTnI assay results in 1571 ED patients with potential acute coronary syndrome (ACS) without ST elevation on electrocardiograph (ECG) were evaluated. The primary outcome was diagnosis of index AMI adjudicated by cardiologists using the local cTnI assay results taken ≥6 h after presentation, ECGs and clinical information. Stored samples were later analysed with hs-cTnT and hs-cTnI assays.
The ROC analysis for AMI (204 patients; 13.0%) for hs-cTnT and hs-cTnI after 2h was 0.95 (95% CI: 0.94-0.97) and 0.98 (95% CI: 0.97-0.99) respectively. The sensitivity, specificity, PLR, and NLR of hs-cTnT and hs-cTnI for AMI after 2h were 94.1% (95% CI: 90.0-96.6) and 95.6% (95% CI: 91.8-97.7), 79.0% (95% CI: 76.8-81.1) and 92.5% (95% CI: 90.9-93.7), 4.48 (95% CI: 4.02-5.00) and 12.86 (95% CI: 10.51-15.31), and 0.07 (95% CI: 0.04-0.13) and 0.05 (95% CI:0.03-0.09) respectively.
Exclusion of AMI 2h after presentation in emergency patients with possible ACS can be achieved using hs-cTnT or hs-cTnI assays. Significant differences in specificity of these assays are relevant and if using the hs-cTnT assay, further clinical assessment in a larger proportion of patients would be required.
采用高敏肌钙蛋白检测法测得的肌钙蛋白浓度在许多急诊科患者中升高;然而,许多患者并未被诊断为急性心肌梗死(AMI)。尚未有关于早期使用(就诊后2小时)高敏心肌肌钙蛋白T(hs-cTnT)和高敏心肌肌钙蛋白I(hs-cTnI)检测法诊断AMI的临床比较报道。
对1571例心电图(ECG)无ST段抬高、疑似急性冠状动脉综合征(ACS)的急诊科患者的早期(0小时和2小时)hs-cTnT和hs-cTnI检测结果进行评估。主要结局是由心脏病专家根据就诊后≥6小时采集的局部cTnI检测结果、ECG和临床信息判定的索引AMI诊断。随后对储存的样本进行hs-cTnT和hs-cTnI检测分析。
2小时后hs-cTnT和hs-cTnI对AMI(204例患者;13.0%)的ROC分析分别为0.95(95%CI:0.94-0.97)和0.98(95%CI:0.97-0.99)。2小时后hs-cTnT和hs-cTnI对AMI的敏感性、特异性、阳性似然比和阴性似然比分别为94.1%(95%CI:90.0-96.6)和95.6%(95%CI:91.8-97.7),79.0%(95%CI:76.8-81.1)和92.5%(95%CI:90.9-93.7),4.48(95%CI:4.02-5.00)和12.86(95%CI:10.51-15.31),以及0.07(95%CI:0.04-0.13)和0.05(95%CI:0.03-0.09)。
对于可能患有ACS的急诊患者,就诊后2小时使用hs-cTnT或hs-cTnI检测法可排除AMI。这些检测法在特异性方面的显著差异具有相关性,若使用hs-cTnT检测法,则需要对更大比例的患者进行进一步的临床评估。